Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis

Immune checkpoint inhibitors (ICIs) have provided tremendous clinical benefit in several cancer types. However, systemic activation of the immune system also leads to several immune-related adverse events. Of these, ICI-mediated colitis (IMC) occurs frequently and is the one with the highest absolut...

Descripción completa

Detalles Bibliográficos
Autores principales: Westdorp, Harm, Sweep, Mark W. D., Gorris, Mark A. J., Hoentjen, Frank, Boers-Sonderen, Marye J., van der Post, Rachel S., van den Heuvel, Michel M., Piet, Berber, Boleij, Annemarie, Bloemendal, Haiko J., de Vries, I. Jolanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586074/
https://www.ncbi.nlm.nih.gov/pubmed/34777387
http://dx.doi.org/10.3389/fimmu.2021.768957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586074/
https://www.ncbi.nlm.nih.gov/pubmed/34777387
http://dx.doi.org/10.3389/fimmu.2021.768957

Ejemplares similares